Adetunji Toriola, MD, MPH, PhD

Adetunji_ToriolaAssistant Professor, Division of Public Health Sciences
Department of Surgery
toriolaa@wudosis.wustl.edu
(314) 286-2668

Dr. Toriola trained and worked as a physician and subsequently became interested in public health and cancer prevention. Afterwards, he undertook trainings in public health (MPH), epidemiology (PhD) in Finland, and a postdoctoral fellowship in cancer epidemiology and prevention at the German Cancer Research Center (DKFZ), Heidelberg, Germany. Dr. Toriola is a molecular cancer epidemiologist, whose research focus is on the utility of biomarkers to elucidate the associations of energetics, hormones and inflammation with cancer risk and mortality, particularly ovarian, breast cancers and gastrointestinal cancers. He has taken leading roles in studies conducted within large cohorts such as the Women’s Health Initiative Observational Study, Finnish Maternity Cohort, and Kuopio Ischemic Heart Disease Risk Factor Study.

Selected Publications

  1. Toriola AT, Jingxia Liu, Patricia A. Ganz, Graham A. Colditz, Lin Yang, Sonya Izadi, Michael J. Naughton, Anna L. Schwartz, Kathleen Y. Wolin. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors. Breast Cancer Res Treat. 2015;152(3):637-43.

  2. Toriola AT, Fields R. Inflammatory, insulin resistance metabolic markers and pancreatic cancer: Quo vadis. Future Oncology 2014;10(9):1519-22.

  3. Ulrich CM, *Rankin C, *Toriola AT, Makar KW, Altug-Teber Ö, Benedetti JK, Holmes RS, Smalley SR, Blanke DS, Lenz H-J. Polymorphisms in folate-metabolizing enzymes and response to 5-fluorouracil among stage II or III rectal cancer patients (INT-0144; SWOG 9304). Cancer 2014: 1;120(21):3329-37. PMID: 25041994 *Equal contribution. 

  4. Toriola AT, Nguyen N, Scheitler-Ring K, Colditz G. Circulating 25-hydroxyvitamin D (25-OHD) levels and prognosis among cancer patients: a systematic review. Cancer Epidemiol Biomark Prev. 2014:23(6); 917-933. PMID: 24692501. 

  5. Toriola AT, Stolzenberg-Solomon R, Dalidowitz L, Linehan D, Colditz G. Diabetes and pancreatic cancer survival: a prospective cohort-based study. Br J Cancer 2014:111(1): 181-5.

  6. Toriola AT, Tolockiene E, Schock H, Surcel H-M, Zeleniuch-Jacquotte A, Wadell G, Toniolo P, Lundin E, Grankvist K, Lukanova A. Free beta human chorionic gonadotropin, total human chorionic gonadotropin and maternal risk of breast cancer. Future Oncology Future Oncology 2014:10(3):377-84. PMID: 24559445. 

  7. Toriola AT, Laukannen JA, Kurl S, Nyyssonen K, Ronkainen K, Kauhanen J. Pre-diagnostic circulating markers of inflammation and risk of prostate cancer. International Journal of Cancer 2013:133 (12); 2961-7.

  8. Kraus S, Hummler S, Toriola AT, Poole EM, Scherer D, Kotzmann J, Makar KW, Kazanov D, Galazan L, Naumov I, Coghill AE, Duggan D, Gigic B, Arber N, Ulrich CM. Impact of genetic polymorphisms on adenoma recurrence and toxicity in a COX-2 inhibitor (celecoxib) trial: results from a pilot study. Pharmacogenetics and genomics 2013;23(8):428-37. 

  9. Toriola AT, Colditz GA. Trends in breast cancer incidence and mortality in the United States: implications for prevention. Breast Cancer Res Treat 2013;138(8):665-73. PMID: 23546552.

  10. Toriola AT, Cheng T-YD, Neuhouser ML, Wener MH, Zheng Y, Brown E, Miller JW, Song X, Beresford SAA, Gunter MJ, Caudill MA, Ulrich CM. Biomarkers of inflammation are associated with colorectal cancer risk in women but are not suitable as early detection markers. Int J Cancer 2013:132(11):2648-59. PMID: 23161620.

  11. Ulrich CM, Toriola AT, Koepl LM, Sandifer T, Poole EM, Duggan C, McTiernan A, Issa JP. Metabolic, hormonal and immunological associations with global DNA methylation among postmenopausal women. Epigenetics 2012;7(9):1020-1028.

  12. Toriola AT, Ulrich CM. Is there a potential use for C-reactive protein as a diagnostic and prognostic marker for colorectal cancer? Future Oncology 2011; 7(10): 1125-8. PMID: 21992725.

  13. Toriola AT, Grankvist K, Agborsangaya C, Lukanova A, Lehtinen M, Surcel HM. Changes in C-reactive protein concentrations and the risk of ovarian cancer: a longitudinal study. Ann Oncol 2011; 22(8): 1916-1921. PMID: 21292643.

  14. Toriola AT, Lundin E, Lehtinen M, Grankvist K, Pukkala E, Chen T, Zeleniuch-Jacquotte A, Toniolo P, Lehtinen M, Surcel HM, Lukanova A. Circulating insulin-like growth factor-I in pregnancy and maternal risk of breast cancer. Cancer Epidemiol Biomark Prev 2011;20(8):1798-1801. PMID: 21680537 PMCID: PMC3153607.

  15. Toriola AT, Surcel H-M, Agborsangaya C, Grankvist K, Luostarinen T, Lukanova A, Pukkala E, Lehtinen M. Independent and joint effects of serum 25-hydroxyvitamin D and calcium on ovarian cancer risk: a prospective nested case-control study. Eur J Cancer 2010;46;2799-2805

Dr. Toriola on PubMed.